摘要 |
The invention provides 15beta-substituted steroidal compounds having selective estrogen receptor activity according to Formula (I) wherein, R<SUP>1 </SUP>is H, C<SUB>1-5 </SUB>alkyl, C<SUB>1-12 </SUB>acyl, di-(C<SUB>1-5 </SUB>alkyl)aminocarbonyl, (C<SUB>1-5</SUB>alkyl)oxycarbonyl or sulfamoyl, R<SUP>2 </SUP>is H, C<SUB>1-3</SUB>alkyl, C<SUB>2-3</SUB>alkenyl or C<SUB>2-3</SUB>alkynyl, each of which may be optionally substituted with a halogen, R<SUP>3 </SUP>is C<SUB>1-2</SUB>alkyl, ethenyl or ethynyl, each of which may be optionally substituted with a halogen, and R<SUP>4 </SUP>is H or C<SUB>1-12 </SUB>acyl.
|